EMBRACE is a randomized, controlled, multi-domain, blinded clinical trial involving 120 community-dwelling older adults at risk of cognitive decline, lasting 12 months. Participants are randomized 1:1 to either a multicomponent intervention group, including cognitive and language training, physical activity, nutritional counseling with oral health support, and financial and digital literacy education, or to a control group receiving regular health counseling. The trial evaluates the effects of the intervention on cognitive performance, quality of life, functionality, financial literacy, digital inclusion, and other health-related outcomes.
MoCA ≥ 17 (Portuguese cutoff point to differentiate between mild cognitive impairment and dementia);
Bedside ≥ 20 for literate individuals or 12 for illiterate individuals.
Malignant diseases;
Diagnosed major depressive disorder;
Dementia/substantial cognitive decline (MoCA < 17);
Symptomatic cardiovascular disease;